Clinical Trial: Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477808) titled 'Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer' on March 12.

Brief Summary: This study is a prospective, randomized, parallel-controlled clinical trial, primarily aimed at evaluating the level of body weight improvement of megestrol acetate combined with standard treatment compared with standard treatment in the first-line treatment of non-small cell lung cancer.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Non-small Cell Lung Cancer

Intervention: DRUG: Nanocrystalline Megestrol Acetate Oral Suspension

Nanocrystalline Megestrol Acetate Oral Suspension (125 mg/mL) was...